FSCPX, a Chemical Widely Used as an Irreversible A1 Adenosine Receptor Antagonist, Modifies the Effect of NBTI, a Nucleoside Transport Inhibitor, by Reducing the Interstitial Adenosine Level in the Guinea Pig Atrium
Based on in silico results, recently we have assumed that FSCPX, an irreversible A1 adenosine receptor antagonist, inhibits the action of NBTI that is apparent on E/c curves of adenosine receptor agonists. As a mechanism for this unexpected effect, we hypothesized that FSCPX might modify the equilib...
Main Authors: | Tamas Erdei, Adrienn Monika Szabo, Nora Lampe, Katalin Szabo, Rita Kiss, Judit Zsuga, Csaba Papp, Akos Pinter, Andras Jozsef Szentmiklosi, Zoltan Szilvassy, Bela Juhasz, Rudolf Gesztelyi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/23/9/2186 |
Similar Items
-
An Advanced in Silico Modelling of the Interaction between FSCPX, an Irreversible A<sub>1</sub> Adenosine Receptor Antagonist, and NBTI, a Nucleoside Transport Inhibitor, in the Guinea Pig Atrium
by: Adrienn Monika Szabo, et al.
Published: (2019-06-01) -
Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life
by: Judit Zsuga, et al.
Published: (2017-05-01) -
A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A<sub>1</sub> Adenosine Receptor Antagonist So Far
by: Gabor Viczjan, et al.
Published: (2021-09-01) -
The Inside Story of Adenosine
by: Marcella Camici, et al.
Published: (2018-03-01) -
Regulation of inflammation by adenosine
by: Bruce Neil Cronstein, et al.
Published: (2013-04-01)